1.
Papp K, Szepietowski J, Kircik L, Toth D, Eichenfeld L, Forman S, Kuligowski M, Venturanza M, Sun K, Simpson E. Long-Term Safety and Disease Control With Ruxolitinib Cream in Atopic Dermatitis: Results From Two Phase 3 Studies. J of Skin [Internet]. 2021Nov.5 [cited 2022Aug.20];5(6):s63. Available from: https://jofskin.org/index.php/skin/article/view/1414